Physiological Augmentation of Mindfulness Meditation
PAMM
1 other identifier
interventional
65
1 country
2
Brief Summary
The purpose of the study is to compare the efficacy of a physiologically-augmented breath-focused mindfulness-based intervention to reduce symptoms of dissociation that are associated with psychological trauma, as well as symptoms of posttraumatic stress disorder (PTSD). The study will evaluate whether physiological augmentation produces a greater change in dissociative symptoms, meditative engagement and attentional control, compared to non-augmented mindfulness. The augmentation comprises physiological feedback in the form of a vibration on the wrist. Vibrations are delivered by a device that will be placed on a participant's arm; the device vibrates in proportion to the person's breath.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2016
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2016
CompletedFirst Submitted
Initial submission to the registry
April 6, 2016
CompletedFirst Posted
Study publicly available on registry
April 28, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 21, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
September 21, 2021
CompletedResults Posted
Study results publicly available
October 17, 2022
CompletedOctober 17, 2022
September 1, 2022
5.6 years
April 6, 2016
September 20, 2022
September 20, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Multiscale Dissociation Inventory (MDI) Score
The MDI is a 30-item self-report test of dissociative symptomology and it measures six different types of dissociative response. The scales of the MDI are disengagement, depersonalization, derealization, emotional constriction/numbing, memory disturbance, identity dissociation, and total dissociation. Items are scored from 1 to 5 where 1 = never and 5 = very often. Total scores range from 30 to 150 where higher scores indicate greater symptoms of dissociation.
Baseline, Week 4 (post-treatment), Week 8 (one month post-treatment)
Modified PTSD Symptom Scale (MPSS) Score
The MPSS is an 18-item instrument assessing the presence and severity of PTSD symptoms related to specific traumatic events in individuals with a known trauma history. Respondents indicate how frequently they experience each item on a scale of 0 to 3 where 0 = not at all and 3 = almost always. PTSD symptomatology over the prior 2 weeks is assessed, yielding a continuous measure of PTSD symptom severity ranging from 0 to 54. A higher score indicates greater symptom severity.
Baseline, Week 4 (post-treatment), Week 8 (one month post-treatment)
Kentucky Mindfulness Scale Score
The Kentucky Mindfulness Scale is a 39-item scale that assesses skills related to what one does while practicing mindfulness. Items are rated on a 5 point Likert scale ranging from 1 (never or very rarely true) to 5 (almost always or always true). Items reflect either direct descriptions of the mindfulness skills, or they describe the absence of that skill and are reverse scored. Total scores range from 39 to 195 and higher scores reflect more mindfulness.
Baseline, Week 4 (post-treatment), Week 8 (one month post-treatment)
Multidimensional Assessment of Interoceptive Awareness Score
This is a clinical measure that assesses various aspects of interoception, including ability to attend to body sensations, regulate distress by attending to body sensations, and experiencing body sensations as safe and trustworthy. The instrument includes 32 items and which are scored from 0 to 5, where 0 = never and 5 = always. Total scores range from 0 to 160 and higher scores indicate greater awareness of body sensations.
Baseline, Week 4 (post-treatment), Week 8 (one month post-treatment)
Other Outcomes (16)
Change in Clinician Administered PTSD Scale (CAPS) Score
Baseline
Change in Mini International Neuropsychiatric Interview (MINI) Score
Baseline
Change in Kreek-McHugh-Schluger-Kellogg (KMSK) Marijuana/Cannabis Scale Score
Baseline
- +13 more other outcomes
Study Arms (2)
Breath-Focused Meditation
EXPERIMENTALWomen with post traumatic stress disorder (PTSD) will receive breath-focused meditation.
Breath-Focused Meditation + Physiological Feedback
EXPERIMENTALWomen with post traumatic stress disorder (PTSD) will receive breath-focused meditation and physiological feedback.
Interventions
Participants will attend two breath-focused meditation sessions per week for three weeks. During the breath focus task, participants are asked to alternatively focus their breathing (1.5 minutes of breathing and 15 seconds of rest). Participants will be asked to "attend to the changing patterns of physical sensations as the breath moves in and out of your body. Focus your awareness on any sensations you may experience (e.g., your abdominal wall rising). Follow the sensations as you breathe in and all the way through until your breath leaves your body".
Participants will receive breath feedback, via dynamic velocity estimates from a respiration belt, which allows an analog of breath to be felt as vibration on their wrist via a tactile transducer on a table. The transducer is tuned to produce low frequencies so there is more vibration and less of an audible component than a regular speaker would produce.
Eligibility Criteria
You may qualify if:
- Experience of at least one Criterion A trauma
- Presence of current symptoms of post traumatic stress disorder (PTSD) that are significantly interfering with functioning
- Multiscale Dissociation Inventory depersonalization score of 7
- Fulfill at least two of the Clinician Administered PTSD Subscale criteria of clinically significant re-experiencing, avoidance, alterations in mood and cognitions, hyperarousal
- Willingness to participate in the study
You may not qualify if:
- Actively psychotic
- Cognitively compromised
- Pregnancy
- Substance or Alcohol Dependence
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Emory Universitylead
- University of Pittsburghcollaborator
Study Sites (2)
Grady Health System
Atlanta, Georgia, 30303, United States
Wesley Woods Center
Atlanta, Georgia, 30329, United States
Related Publications (1)
Powers A, Dixon HD, Guelfo A, Mekawi Y, Bradley B, Kaslow N, Fani N. The mediating role of emotion dysregulation in the association between trait mindfulness and PTSD symptoms among trauma-exposed adults. Mindfulness (N Y). 2021 Sep;12(9):2229-2240. doi: 10.1007/s12671-021-01684-8. Epub 2021 Jul 16.
PMID: 34603539DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Negar Fani, PhD
- Organization
- Emory University
Study Officials
- PRINCIPAL INVESTIGATOR
Negar Fani, PhD
Emory University
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
April 6, 2016
First Posted
April 28, 2016
Study Start
March 1, 2016
Primary Completion
September 21, 2021
Study Completion
September 21, 2021
Last Updated
October 17, 2022
Results First Posted
October 17, 2022
Record last verified: 2022-09
Data Sharing
- IPD Sharing
- Will not share